Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronocort in Adults With Congenital Adrenal Hyperplasia
NCT01735617Phase 2Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Dec 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrocortisone in congenital adrenal hyperplasia (CAH), sponsored by Neurocrine Biosciences. Started Dec 2012; status: completed.
02
Drugs
hydrocortisone
03
Conditions
congenital adrenal hyperplasia (CAH)
Beyond the preview
Go deeper on NCT01735617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01735617.